NCT06821126 - Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults | Biotech Hunter

Enrollment

238

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

March 31, 2028

Conditions

Healthy

Interventions

BIOLOGICAL

LVT-001

Intranasal administration

BIOLOGICAL

Cormirnaty

Intramuscular administration

Trial Locations (5)

NOT_YET_RECRUITING

CHU Dijon Bourgogne - Centre d'Investigation Clinique 1432, Dijon

RECRUITING

CHRU de Tours - Centre d'Investigation Clinique 1415, Tours

NOT_YET_RECRUITING

CHU de Saint-Etienne - Service des Maladies Infectieuses, Saint-Priest-en-Jarez

NOT_YET_RECRUITING

HCL - Hôpital de la Croix-Rousse - Service des Maladies Infectieuses et Tropicales, Lyon

NOT_YET_RECRUITING

APHP - Hôpital Cochin - Centre d'Investigation Clinique de Vaccinologie Cochin-Pasteur 1417, Paris